Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Azeem, M. Cancemi, P. Mukhtar, F. Marino, S. Peri, E. Di Prima, G. De Caro, V.

Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Saif-Ur-Rahman, K. King, C. Whelan, S. O. Blair, M. Donohue, S. Madden, C. Kothari, K. Sommer, I. Harder, T. Dauby, N. et al.,

Efficacy and safety of respiratory syncytial virus vaccines

  • All age groups
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Gyawali, R. Poudyal, N. Docherty, A.

Efficacy and Safety of Tetanus-Toxoid Conjugate Typhoid Vaccine (Vi-TT) in Children and Adolescents: A Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Adolescents
  • Typhoid
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2025 ∙ Volonte, S. De Vicari, D. Cola, A. Barba, M. Frigerio, M.

Efficacy and Safety of Uro-Vaxom in Urinary Tract Infection Prevention: A Systematic Literature Review

  • Adults
  • Older adults
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Inauen, J. LaBroome, S. Maldari, A. Stevens, N. E. Geake, J. B. Lynn, D. J. Barry, S.

Efficacy of Bacille Calmette-Guerin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control Trials

  • Adults
  • Older adults
  • Healthcare workers
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Rossi, Y. I. Bolner, G. Dolovitsch De Oliveira, F. Costa Dall'Acqua, J. Antunes Do Livramento Junior, V. Dias, C. A. G.

Efficacy of Bacillus Calmette-Guerin revaccination in preventing tuberculosis disease: A systematic review and meta-analysis

  • All age groups
  • Tuberculosis
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Xia, Z. Meng, J. Wang, X. Liu, P. Wu, Y. Xiong, Y. He, B. Gao, S.

Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: A meta-analysis of randomized controlled trials

  • All age groups
  • Healthcare workers
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Bland, H. Harwood, J. Chua, J. Roberts, N. Azad, T. Lee, J. J. Albury, C.

Efficacy of behaviour change interventions to influence human papillomavirus (HPV) vaccine uptake: a systematic review and behaviour change techniques analysis

  • Adolescents
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Kardoust Parizi, M. Singla, N. Matsukawa, A. Tsuboi, I. Mancon, S. Miszczyk, M. Chlosta, P. Shariat, S. F.

Efficacy of human papillomavirus vaccines in the prevention of male genital diseases: a systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Naderian, R. Eslami, M. Ahmad, S. Paraandavaji, E. Yaghmayee, S. Soltanipur, M. Naderian, R. Pajand, O. Tajdini, P. Alizadeh, A. Sanami, S.

Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review

  • Adolescents
  • Dengue
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...